Having trouble accessing articles? Reset your cache.

Aveo Pharmaceuticals, Merck deal

Merck terminated a 2007 deal and returned worldwide rights to Aveo for cancer

Read the full 138 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE